Which are the symptoms of Lysosomal acid lipase deficiency?

Lysosomal acid lipase deficiency (LAL-D) is a rare, multisystem metabolic disorder that causes the harmful accumulation of cholesteryl esters and triglycerides in tissues throughout the body, leading to symptoms ranging from severe infantile liver failure to progressive liver fibrosis and dyslipidemia in children and adults. The clinical presentation of Lysosomal acid lipase deficiency is highly variable, depending on the residual enzyme activity, often manifesting as hepatomegaly, elevated liver enzymes, and abnormal lipid profiles.

What are the most common symptoms of Lysosomal acid lipase deficiency?

The symptoms of Lysosomal acid lipase deficiency are primarily driven by the body's inability to break down fats, which then accumulate in the liver, spleen, and intestinal wall. In the most severe form, known as Wolman disease, infants typically present within the first few weeks of life with severe malabsorption, failure to thrive, persistent vomiting, diarrhea, and massive enlargement of the liver and spleen (hepatosplenomegaly). In the later-onset form, formerly known as cholesteryl ester storage disease (CESD), patients may appear asymptomatic for years, though they often present with:

• Hepatomegaly (enlarged liver) or splenomegaly (enlarged spleen) identified during routine physical exams.


• Abnormal lipid profiles, specifically high LDL-cholesterol and low HDL-cholesterol.


• Elevated transaminases (ALT/AST), indicating ongoing liver stress.


• Gastrointestinal distress, including chronic abdominal pain or steatorrhea (fatty stools).


• Premature atherosclerosis, which can lead to early cardiovascular events.

How do symptoms vary in severity and progression?

The severity of Lysosomal acid lipase deficiency is inversely related to the amount of residual LAL enzyme activity. While Wolman disease is rapidly progressive and typically fatal within the first year of life without intervention, the later-onset form of Lysosomal acid lipase deficiency progresses more slowly. Over time, individuals with the later-onset form are at significant risk for developing liver fibrosis, cirrhosis, and ultimately liver failure. Because the progression is often silent, many patients are not diagnosed until irreversible liver damage has occurred.

Which symptoms most impact daily quality of life?

For individuals living with Lysosomal acid lipase deficiency, the most impactful symptoms are often related to chronic gastrointestinal issues and the psychological burden of managing a progressive metabolic condition. Fatigue, persistent abdominal discomfort, and the dietary restrictions required to manage lipid levels can significantly interfere with daily activities. As part of the DiseaseMaps community, we have seen that 5 individuals with this condition have shared their experiences, highlighting the importance of peer support in managing the daily uncertainty of this rare diagnosis.

When should you seek immediate medical attention?

Patients and caregivers should seek immediate medical evaluation if they notice signs of acute liver decompensation or severe metabolic distress. Warning signs include jaundice (yellowing of the skin or eyes), unexplained bruising or bleeding (indicating impaired clotting factors), severe abdominal swelling, or signs of cardiovascular distress such as chest pain or sudden shortness of breath. Because Lysosomal acid lipase deficiency affects multiple systems, any sudden change in energy levels or physical function should be discussed with a specialist.

Next steps

• Consult a metabolic specialist or hepatologist who has experience managing lysosomal storage disorders.


• Request a diagnostic blood test for LAL enzyme activity or genetic testing to confirm the diagnosis.


• Join a patient advocacy group or the DiseaseMaps.org community to connect with other families navigating the same path.


• Discuss current therapeutic options, such as enzyme replacement therapy, with your medical team to mitigate long-term organ damage.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Lysosomal acid lipase deficiency.


• Orphanet: Lysosomal acid lipase deficiency (ORPHA:79275).


• OMIM (Online Mendelian Inheritance in Man): Acid Lipase Deficiency; LAL D.


• National Organization for Rare Disorders (NORD): Lysosomal Acid Lipase Deficiency.